Parexel
Parexel made several appointments in February to bolster its oncology expertise.
Joining the company’s regulatory consulting team, a role in which she will focus on building the Parexel’s new cross-functional oncology initiative, is Amy McKee, MD, former deputy director of the US Food and Drug Administration’s (FDA) Oncology Center of Excellence.
McKee told us, “In this new role, I hope to partner with clients to shepherd promising new therapies through traditional and novel development pathways as well as forge relationships across Parexel to bring a comprehensive, cohesive oncology expertise to our clients.”
McKee is a board-certified pediatric hematologist-oncologist with expertise in the treatment of neuroblastoma.
